SEPTInvestingStart Free

LXEO SCHEDULE 13G: SEC filing

OrbiMed Advisors LLC and OrbiMed Capital LLC

Filed with the SEC on · accession 0000947871-26-000801

LXEO filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.4% by the first close after the filing.

Summary of the filing

OrbiMed Advisors LLC and OrbiMed Capital LLC filed a joint Schedule 13G disclosing a passive ownership position in Lexeo Therapeutics, Inc. common stock as of June 30, 2026.

For details, click here →

Key details

Reporting person / filerOrbiMed Advisors LLC
Reporting person / filerOrbiMed Capital LLC
IssuerLexeo Therapeutics, Inc.
Member, orbimed advisors llc and orbimed capital llcCarl L. Gordon

How LXEO stock reacted

Close before

$4.96

Aug 13, 2026

First close after

-2.42%

$4.84

5 trading days

+2.02%

$5.06

Since filing

-41.73%

$2.89

✦ Ask GOAX AI about this filing — what it means for LXEO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LXEO?

Click here

Frequently asked questions

What did LXEO file with the SEC on Aug 14, 2026?

LXEO filed a SCHEDULE 13G (SEC filing). OrbiMed Advisors LLC and OrbiMed Capital LLC filed a joint Schedule 13G disclosing a passive ownership position in Lexeo Therapeutics, Inc. common stock as of June 30, 2026.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did LXEO stock react to this filing?

LXEO closed at $4.96 before the filing and $4.84 on Aug 14, 2026 (-2.42%). Five trading days later: $5.06 (+2.02%).

Other LXEO SEC filings

Get alerts when LXEO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
LXEO overviewLXEO analysisLXEO newsLatest SEC filings